Bris­tol My­ers drops an­oth­er Cy­tomX pro­gram

Bris­tol My­ers Squibb dropped an­oth­er CT­LA-4 pro­gram from its decade-long re­search col­lab­o­ra­tion with Cy­tomX af­ter the big phar­ma re­viewed its port­fo­lio.

Cy­tomX an­nounced the change …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.